Novo Nordisk says Wegovy approved in China for liver disease MASH

Denmark's Novo Nordisk said ‌on Thursday its blockbuster weight-loss drug Wegovy ​had been ​approved in China as the ⁠first GLP-1 ​RA class of drugs ​for the treatment of metabolic dysfunction-associa...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。